<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345967</url>
  </required_header>
  <id_info>
    <org_study_id>PR13-004</org_study_id>
    <nct_id>NCT02345967</nct_id>
  </id_info>
  <brief_title>Function of Implanted Glucose Sensor 2</brief_title>
  <acronym>FIGS-2</acronym>
  <official_title>Function of Implanted Glucose Sensor 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlySens Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Profil Institute for Clinical Research, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AMCR Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>GlySens Incorporated</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to verify safety and assess tolerance of a long-term, implanted
      glucose monitoring sensor. The study will also provide data to characterize the response
      properties and calibration of the implanted sensor and determine if such properties vary with
      implant duration.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">May 30, 2018</completion_date>
  <primary_completion_date type="Actual">May 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Adverse Events</measure>
    <time_frame>From enrollment to 2-weeks post-explant</time_frame>
    <description>Incidence of adverse events related to the Intervention</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Model 100 Sensor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Model 100 Sensor</intervention_name>
    <description>One Model 100 Sensor to be implanted per subject.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Either: (1) male or (2) female and not pregnant, breastfeeding, or planning to become
             pregnant

          -  Diabetes diagnosis of type 1, or type 2 using insulin

          -  Under the routine care of a physician for diabetes treatment

          -  Able to understand and follow directions

          -  History of compliance with diabetes care regimen

          -  Able to comply with study requirements regarding planned clinical visits and exams

          -  In good physical condition without major medical concerns or blood chemistry
             abnormalities

        Exclusion Criteria:

          -  Mental disorders that might affect compliance to protocols

          -  Diabetes diagnosis type 2 where treatment involves (1) oral medication without insulin
             or (2) insulin use restricted to a single daily injection of long-acting insulin or
             (3) control by diet/exercise regimen alone

          -  History of intolerance or sensitivity to any of the device materials

          -  History of any adverse reaction or allergy to any of the drugs/agents utilized in the
             study procedures

          -  History of recurrent skin infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda Morrow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Profil Institute for Clinical Research, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Profil Institute for Clinical Research</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AMCR Institute</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>January 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>June 11, 2018</last_update_submitted>
  <last_update_submitted_qc>June 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes mellitus requiring insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

